The US Department of Justice has sent a letter to Yale School of Medicine, alleging it was illegally discriminating against applicants who are not Black or Hispanic. This move comes as part of a broader investigation into potential biases in medical school admissions.
What Happened
The Justice Department's letter to Yale is the latest development in a long-standing debate over affirmative action policies in higher education. The department has also sent a similar letter to UCLA's medical school. The accusations center on the schools' use of race as a factor in admissions decisions, which the Justice Department argues is discriminatory against white and Asian applicants.
Why It Matters
The debate over affirmative action has significant implications for the future of higher education and the medical profession. Proponents of affirmative action argue that it is necessary to address historical disparities in access to education and healthcare. Opponents, on the other hand, argue that it is unfair to use race as a factor in admissions decisions.
What Experts Say
"The use of race in admissions decisions is a complex issue that requires careful consideration." — **Dr. David A. Acosta**, President of the National Hispanic Medical Association
Key Numbers
- **42%: The percentage of white students who make up the entering class at Yale School of Medicine, according to the Justice Department's letter.
- **24%: The percentage of Asian students who make up the entering class at UCLA's medical school, according to the Justice Department's letter.
Background
The debate over affirmative action in higher education has been ongoing for decades. In 2019, a federal judge ruled that Harvard University's admissions policies were not discriminatory, but the Justice Department has continued to investigate potential biases in admissions decisions.
What Comes Next
The accusations against Yale and UCLA's medical schools are likely to have significant implications for the future of affirmative action policies in higher education. The Supreme Court's decision to preserve access to a widely used abortion pill also has significant implications for reproductive rights.
Abortion Access
The Supreme Court's decision to preserve access to the abortion drug mifepristone has been hailed as a victory for reproductive rights advocates. The decision comes as part of a broader lawsuit challenging the FDA's approval of the drug.
Public Health Concerns
Alcohol is a major public health concern, but it is often overlooked in favor of other issues. A new series from STAT explores the impact of alcohol on public health.
Key Facts
- Who: The US Department of Justice
- What: Accused Yale and UCLA's medical schools of discriminating against white and Asian applicants
What to Watch
- The outcome of the lawsuit challenging the FDA's approval of the abortion drug mifepristone
- The Justice Department's ongoing investigation into potential biases in medical school admissions